Astorg completed the acquisition of a majority stake in hg medical from NORD Holding.

Astorg, a private equity firm, completed the acquisition of a majority stake in hg medical, a contract manufacturer of high-quality orthopaedic implants specialising in lower extremities, upper extremities and in the spine sector, from NORD Holding, a private equity asset manager focusing on fund investments and direct investments. Financial terms were not disclosed. “Hg medical will be a terrific addition to Astorg’s portfolio and a great fit with our Healthcare strategy focused on MedTech, Pharma Services and Life Science Tools. It is Astorg Mid-Cap’s second investment in Healthcare and it will benefit from Astorg’s experience in CDMO as well as our broader MedTech ecosystem. hg medical’s contribution to people’s well-being is also in line with Astorg’s impact commitment, one of our four sustainability pillars. We look forward to working with Craig and Johannes to scale hg’s platform across the most attractive and demanding orthopaedic applications,” Edouard Pillot, Astorg Mid-Cap Managing Partner and Co-Head.